Mergent, Inc. Announces Changes to the HealthShares Metabolic-Endocrine Disorders Index
NEW YORK, June 2 /PRNewswire/ -- Mergent, Inc., administrator
for the HealthShares(TM) Indexes, a series of 20 underlying indexes
for the HealthShares(TM) Exchange Traded Funds, today announced the
following changes effective on the opening of trading on Thursday,
June 5, 2008: NeuroSearch AS (Copenhagen: NEUR) will replace
Sirtris Pharmaceuticals, Inc. (NASDAQ:SIRT) in the HealthShares(TM)
Metabolic-Endocrine Disorders Index. Sirtris Pharmaceuticals, Inc.
is being acquired by GlaxoSmithKline plc (NYSE:GSK) .
Companies included in the HealthShares(TM) Metabolic-Endocrine
Disorders Index are engaged in the research, clinical development
and/or commercialization of therapeutic agents for the treatment of
a wide variety of metabolic-endocrine disorders including, but not
limited to, diabetes, obesity, Syndrome X, growth deficiency and
rare lysosomal disorders.
About Mergent
Mergent, Inc., a Xinhua Finance company (TSE Mothers: 9399; OTC
ADRs: XHFNY), is the preferred provider of business and financial
data on global publicly listed companies. Headquartered in Fort
Mill, SC and New York City with sales offices in key North American
cities, Mergent also has a strong global presence with offices in
London, Shanghai, Tokyo, Toronto and Sydney. Mergent's databases
contain detailed equity, debt and corporate action information on
over 15,000 U.S. public companies, 20,000 non-U.S. public companies
and all U.S. municipal bonds.
For more than a century, Mergent has been providing solutions to
clients in the investment management, academic, research and
corporate information fields. Today, that unique experience is
combined with leading-edge technology to form a robust, diverse
product line that operates under Mergent's umbrella. These include
Mergent's Dividend Achievers Indices -- the premier benchmark for
long-term returns; Ford Equity Research -- a leading independent
investment research firm; Mergent Online -- a powerful web-based
research portal that provides critical business information to
support daily research and analysis; Mergent Manuals, Handbooks and
Investment Guides; in-depth municipal and corporate fixed-income
data, as well as end-of-day evaluation pricing; EventsData --
providing real-time information on corporate actions, dividend
payouts, news and updates directly to client desktops. For more
information, please visit www.mergent.com and
www.dividendachievers.com.
Source: Mergent, Inc.
CONTACT: Jean Dugan, Director of Sales, Index Services of
Mergent, Inc.,
+1-212-413-7712, Jean.Dugan@mergent.com
Web site: http://www.mergent.com/
http://www.dividendachievers.com/
 |
Pharma Industry News Archive
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
